Sakamoto, Mari
Hasegawa, Takuya
Asakura, Masanori
Kanzaki, Hideaki
Takahama, Hiroyuki
Amaki, Makoto
Mochizuki, Naoki
Anzai, Toshihisa
Hamasaki, Toshimitsu
Kitakaze, Masafumi
Article History
Received: 27 December 2016
Revised: 7 February 2017
Accepted: 15 February 2017
First Online: 6 April 2017
Competing interests
: TH reports personal fees from Takeda Pharmaceutical Company, Daiichi Sankyo Company, Otsuka Pharmaceutical, Bayer Yakuhin, Mitsubishi Tanabe Pharma Corporation, Abbott Vascular Japan and Shionogi & Co. during the conduct of the study; MA reports having received grants from the Japanese Government during the conduct of the study as well as personal fees and non-financial support from Pfizer, personal fees from Boehringer-Ingelheim, personal fees from Tanabe-Mitsubishi, personal fees from Kowa and personal fees from Takeda, which were unrelated to the submitted work; HT reports having received grants from The Bayer Scholarship for Cardiovascular Research and from the Japanese Ministry of Education, Culture, Sports, Science and Technology, which were unrelated to the submitted work; MA reports having received grants from the Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad, grants from the Suzuken Memorial Foundation, non-financial support from Abbott Vascular Japan and non-financial support from the Takeda Pharmaceutical Company, which were unrelated to the submitted work; MK reports having received grants and personal fees from Takeda during the conduct of the study as well as grants from the Japanese Government, the Japan Heart Foundation and the Japanese Cardiovascular Research Foundation, grants and personal fees from Asteras, grants and personal fees from Sanofi, personal fees from Daiichi-Sankyo, grants and personal fees from Pfizer, grants and personal fees from Ono, personal fees from Bayer, grants and personal fees from Novartis, personal fees from Boehringer, grants and personal fees from Tanabe-Mitubishi, personal fees from Kowa, grants and personal fees from Kyowa-Hakko-Kirin, personal fees from Dainihon-Sumitomo, personal fees from Sawai, personal fees from MSD, grants and personal fees from Abbott, grants and personal fees from Otsuka, grants from Calpis, grants from Nihon Kohden, personal fees from Shionogi, personal fees from AstraZeneca, personal fees from Asahikasei Med., personal fees from Novo Nordisk, personal fees from Fuji-film RI and personal fees from Japan Medical Data, which were unrelated to the submitted work. The other authors declare no conflict of interest.
Free to read: This content has been made available to all.